Thyroid Related Quality of Life in Elderly with Subclinical Hypothyroidism and Improvement on Levothyroxine is Distinct from that in Young Patients (TSAGE)

Abstract

The aim of this study was to investigate in a longitudinal approach whether levothyroxine (LT4) substitution has a different impact on quality of life (QoL) and thyroid related QoL in younger (<40 years) and older subjects (>60 years) with elevated thyroid-stimulating hormone (TSH) concentrations. The study included male and female patients with newly diagnosed, untreated subclinical hypothyroidism defined by TSH>8 mU/l. Patients were recruited throughout Germany from 2013–2016 and evaluated by clinical assessment, blood sampling and questionnaires for health related QoL and thyroid-disease thyroid-related QoL (ThyPRO) at time of diagnosis and six months after initiation of LT4 treatment. We found significantly lower QoL in both young and old patients with subclinical hypothyroidism compared to age-matched healthy individuals. Higher scores on follow-up were found in all patients irrespective of age, indicating better QoL on LT4 therapy. Analysis of the ThyPRO questionnaire showed that old patients experienced less Emotional Susceptibility, Tiredness, and Impaired Day Life on LT4, while young patients reported less Cognitive Complaints, Emotional Susceptibility, and Impaired Day Life compared to baseline assessment. Hypothyroidism with TSH concentrations>8 mU/l is associated with impairment in general and ThyPRO QoL in young and old age. Older patients benefited from LT4 therapy and remarkably show similar degree of improvement as younger patients, albeit with some thematic variation in ThyPRO QoL. Our data confirm current recommendations on initiation of LT4 substitution and suggest that this should not be withheld in elderly with TSH concentration above 8–10 mU/l.

Key words

subclinical hypothyroidism - quality of life - aging - elderly - thyroid-stimulating hormone - levothyroxine treatment

Publication History

Received: 28 January 2019

Accepted: 16 April 2019

Article published online:
10 September 2019

• References

• 1 Pearce SH, Brabant G, Duntas LH. et al. ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J 2013; 2: 215-228
• 2 Ross DS, Burch HB, Cooper DS. et al. American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 2016; 26: 1343-1421
• 3 Verma A, Hasan T. Thyroid disorders in older people. Rev Clin Gerontol 2009; 19: 193-206
• 4 Atzmon G, Barzilai N, Hollowell JG. et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009; 94: 1251-1254
• 5 Hollowell JG, Staehling NW, Flanders WD. et al. Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499
• 6 Surks MI, Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010; 95: 496-502
• 7 Gharib H, Tuttle RM, Baskin HJ. et al. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005; 90: 581-585
• 8 Brunner-La Rocca HP, Rickenbacher P. Muzzarelli et al. End-of-life preferences of elderly patients with chronic heart failure. Eur Heart J 2012; 33: 752-759
• 9 Bektas Uysal H, Ayhan M. Autoimmunity affects health-related quality of life in patients with Hashimoto's thyroiditis. Kaohsiung J Med Sci 2016; 32: 427-433
• 10 Watt T, Groenvold M, Rasmussen AK. et al. Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol 2006; 154: 501-510
• 11 Bianchi GP, Zaccheoni V, Solaroli E. et al. Health-related quality of life in patients with thyroid disorders. A study based on Short-Form 36 and Nottingham Health Profile Questionnaires. Qual Life Res 2004; 13: 45-54
• 12 Jaeschke R, Guyatt G, Gerstein H. et al. Does treatment with l-thyroxine influence health status in milddle-aged and older adults with subclinical hypothyroidism?. J Gen Intern Med 1996; 11: 744-749
• 13 Watt T, Cramon P, Hegedus L. et al. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab 2014; 99: 3708-3717
• 14 Winther KH, Cramon P, Watt T. et al. Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS One 2016; 11: e0156925
• 15 Stott DJ, Rodondi N, Kearney PM. et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. N Engl J Med 2017; 376: 2534-2544
• 16 Chueire VB, Romaldini JH, Ward LS. Subclinical hypothyroidism increases the risk for depression in the elderly. Arch Gerontol Geriatr 2007; 44: 21-28
• 17 Larisch R, Kley K, Nikolaus S. et al. Depression and anxiety in different thyroid function states. Horm Metab Res 2004; 36: 650-653
• 18 Watt T, Hegedus L, Groenvold M. et al. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol 2010; 162: 161-167
• 19 Watt T, Barbesino G, Bjorner JB. et al. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Qual Life Res 2015; 24: 769-780
• 20 Bullinger M, Kirchberger I. SF-36 Fragebogen zum Gesundheitszustand. Göttingen: Hogrefe; 1998
• 21 Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum; 1988
• 22 Rosário PW, Carvalho M, Calsolari MR. Natural history of subclinical hypothyroidism with TSH ≤10 mIU/l: a prospective study. Clin Endocrinol 2016; 84: 878-881
• 23 Grossman A, Weiss A, Koren-Morag N. et al. Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study. Am J Med 2016; 129: 423-430
• 24 Karmisholt J, Andersen S, Laurberg P. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur J Endocrinol 2011; 164: 317-323
• 25 Rosario PW, Calsolari MR. Levothyroxine therapy in the subclinical hypothyroidism: a lifelong therapy? A long-term study. Clin Endocrinol (Oxf) 2016; 85: 819-820
• 26 Samuels MH, Schuff KG, Carlson NE. et al. Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab 2007; 92: 2545-2551